These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10199747)

  • 1. Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment.
    Mahler RJ; Adler ML
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1165-71. PubMed ID: 10199747
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin sensitizers.
    Das S
    J Assoc Physicians India; 1997; Suppl 1():32-6. PubMed ID: 11235632
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
    Tatoń J; Koliński P
    Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
    Green J; Feinglos M
    Int J Clin Pract Suppl; 2007 Aug; (154):3-11. PubMed ID: 17593272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and beta-cell function--a clinical perspective.
    Matthews DR
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating type 2 diabetes--today's targets, tomorrow's goals.
    Alberti KG
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S3-10. PubMed ID: 11685827
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pancreatic pacemaker out of rhythm. Disturbed pulsatile insulin release therapeutically interesting in type 2 diabetes].
    Sjöholm A
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2228-9. PubMed ID: 17822199
    [No Abstract]   [Full Text] [Related]  

  • 9. [New hypoglycemic drugs in treatment of diabetes type 2].
    Sokup A; Swiatkowski M
    Przegl Lek; 2000; 57(6):349-52. PubMed ID: 11107871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and pharmacological treatment of insulin resistance.
    Matthaei S; Stumvoll M; Kellerer M; Häring HU
    Endocr Rev; 2000 Dec; 21(6):585-618. PubMed ID: 11133066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive beta cell failure in type 2 diabetes mellitus of youth.
    Gungor N; Arslanian S
    J Pediatr; 2004 May; 144(5):656-9. PubMed ID: 15127006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conversation with John B. Williams, MD, PhD.
    Williams JB
    Manag Care Interface; 2003; Suppl A():8-13. PubMed ID: 12564406
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies.
    Goldfine AB; Simonson DC; Folli F; Patti ME; Kahn CR
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3311-20. PubMed ID: 7593444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of type 2 diabetes--new aspects and clinical consequences].
    Donath MY; Maedler K; Sergeev P; Dyntar D; Thomas D; Spinas GA
    Ther Umsch; 2002 Aug; 59(8):381-5. PubMed ID: 12235729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes: to stimulate or not to stimulate the beta cell.
    Cerasi E
    Metabolism; 2000 Oct; 49(10 Suppl 2):1-2. PubMed ID: 11078467
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes.
    Efrat S
    Int J Exp Diabesity Res; 2003; 4(1):1-5. PubMed ID: 12745664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus: pathogenesis and treatment strategies.
    Skyler JS
    J Med Chem; 2004 Aug; 47(17):4113-7. PubMed ID: 15293979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Type 2 Diabetes: The Evolution of Our Understanding.
    Brunton S
    J Fam Pract; 2016 Apr; 65(4 Suppl):. PubMed ID: 27262256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
    Campbell IW; Charbonnel B
    Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
    Gao H; Xiao W; Wang C; Zhang J; Yang Y; Yang J; Yang W; Hong T
    Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.